A Case of Lenalidomide-Induced Hypersensitivity Pneumonitis

Erika Lerch,Sandor Györik,Jonas Feilchenfeldt,Luca Mazzucchelli,Franco Quadri

A Case of Lenalidomide-Induced Hypersensitivity Pneumonitis

2010

Erika Lerch
Sandor Györik
Jonas Feilchenfeldt
Luca Mazzucchelli
Franco Quadri

Background: Lenalidomide is a new immunomodulatory drug, FDA-approved for the treatment of the 5q-myelodysplastic syndrome and refractory or relapsed multiple myeloma (MM). Regardin

Keywords:

Cancer research
Hypersensitivity pneumonitis
Pathology
Lenalidomide
Immunomodulatory drug
Pulmonary toxicity
Multiple myeloma
Medicine
Proteasome inhibitor
Thalidomide
Internal medicine
Refractory
Gastroenterology
Bortezomib

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations